Behera Dibya Ranjan, Shetty Kiran Kumar
Manipal Hospital, Plot No.1, Besides Satyasai Enclave Khandagiri, Bhubaneswar, India.
Department of Product Performance Engineering & Post Market Clinical Follow Up, Meril Life Sciences, Vapi, Gujarat, India.
J Med Case Rep. 2025 Aug 5;19(1):390. doi: 10.1186/s13256-025-05471-0.
BACKGROUND: Transcatheter aortic valve implantation-in-transcatheter aortic valve implantation represents a progressive solution for patients with degenerated transcatheter heart valves, especially those at high surgical risk. With the increasing use of transcatheter aortic valve implantation worldwide, the need for redo procedures is also rising. Balloon-expandable valves such as the Myval transcatheter heart valve (Meril Life Sciences Pvt. Ltd.) offer design advantages of enhanced radial strength, low-profile frames, and effective sealing, making them suitable for complex valve-in-valve scenarios. An essential procedural concern in redo transcatheter aortic valve implantation is the risk of coronary obstruction, particularly involving the left main coronary artery, requiring pre-emptive planning strategies such as the chimney technique. CASE PRESENTATION: We report the case of a 68-year-old female patient of Indian ethnicity with prior transcatheter aortic valve implantation using a 26 mm CoreValve (Medtronic), presenting with symptomatic valve degeneration. Her case having been deemed high-risk for open surgical intervention, she was selected for a transcatheter aortic valve implantation-in-transcatheter aortic valve implantation procedure. Preprocedural computed tomography imaging showed a critical risk plane for the left main coronary artery, necessitating coronary protection. A 23 mm balloon-expandable Myval transcatheter heart valve was implanted using transfemoral access. Coronary protection was initiated with prepositioning of a coronary guidewire in the left coronary artery. Following valve deployment, the patient developed hypotension with left main coronary artery flow compromise, requiring bailout left main coronary artery stenting, resulting in a chimney configuration. Postdeployment angiography confirmed optimal valve positioning with preserved coronary flow. The patient initially developed hypotension and severe hypokinesia, which was managed successfully with emergency left main coronary artery stenting and supportive care. She exhibited immediate hemodynamic recovery and was discharged in a stable condition. This is the first documented case of a Myval-based transcatheter aortic valve implantation-in-transcatheter aortic valve implantation with left main coronary artery chimney stenting from East India. CONCLUSION: This case highlights the feasibility, safety, and procedural effectiveness of the Myval balloon-expandable transcatheter heart valve in a redo transcatheter aortic valve implantation setting. It also underscores the importance of anatomical evaluation, risk stratification, and pre-emptive coronary protection in complex structural heart interventions. The successful use of the chimney technique reinforces its role in mitigating life-threatening coronary occlusion during valve-in-valve procedures. This report contributes to the growing evidence supporting the use of next-generation transcatheter heart valves for complex redo transcatheter aortic valve implantation scenarios and expands the clinical applicability of Myval in high-risk cases.
背景:经导管主动脉瓣植入术(Transcatheter aortic valve implantation-in-transcatheter aortic valve implantation)是治疗经导管心脏瓣膜退化患者的一种渐进性解决方案,尤其是那些手术风险高的患者。随着经导管主动脉瓣植入术在全球范围内的使用增加,再次手术的需求也在上升。球囊扩张瓣膜,如Myval经导管心脏瓣膜(Meril Life Sciences Pvt. Ltd.),具有增强的径向强度、低轮廓框架和有效密封等设计优势,使其适用于复杂的瓣中瓣情况。再次经导管主动脉瓣植入术中一个重要的操作问题是冠状动脉阻塞的风险,特别是涉及左主冠状动脉,这需要采取如烟囱技术等预先规划策略。 病例报告:我们报告一例68岁印度裔女性患者,此前使用26mm CoreValve(美敦力公司)进行过经导管主动脉瓣植入术,现出现有症状的瓣膜退化。因其病例被认为进行开放手术干预风险高而被选行经导管主动脉瓣植入术 - 经导管主动脉瓣植入术。术前计算机断层扫描成像显示左主冠状动脉存在关键风险平面,需要进行冠状动脉保护。使用经股动脉入路植入一枚23mm球囊扩张式Myval经导管心脏瓣膜。通过在左冠状动脉预先放置冠状动脉导丝开始冠状动脉保护。瓣膜释放后,患者出现低血压且左主冠状动脉血流受损,需要紧急进行左主冠状动脉支架置入,形成烟囱构型。释放后血管造影证实瓣膜位置理想且冠状动脉血流得以保留。患者最初出现低血压和严重运动减弱,通过紧急左主冠状动脉支架置入和支持治疗成功处理。她立即出现血流动力学恢复并在病情稳定后出院。这是东印度地区首例有记录的基于Myval的经导管主动脉瓣植入术 - 经导管主动脉瓣植入术并进行左主冠状动脉烟囱支架置入的病例。 结论:本病例突出了Myval球囊扩张式经导管心脏瓣膜在再次经导管主动脉瓣植入术中应用的可行性、安全性和操作有效性。它还强调了解剖学评估、风险分层和预先冠状动脉保护在复杂结构性心脏干预中的重要性。烟囱技术的成功应用强化了其在瓣中瓣手术中减轻危及生命的冠状动脉闭塞方面的作用。本报告为支持在复杂的再次经导管主动脉瓣植入术场景中使用下一代经导管心脏瓣膜提供了越来越多的证据,并扩大了Myval在高风险病例中的临床适用性。
EuroIntervention. 2025-7-7
EuroIntervention. 2024-11-18
JACC Cardiovasc Interv. 2020-3-23
JACC Cardiovasc Interv. 2019-6-12